Corporate DisclosureIBNSINA
IBNSINA Corporate Disclosure — 6 September 2022
Announcement summary
- What happened
- IBNSINA published a corporate disclosure on 6 September 2022. Read the full announcement for details.
- Company
- The IBN SINA Pharmaceutical Industry PLC
- Announcement published
Original announcement
(Continuation news of IBNSINA): and The IBN SINA Natural Medicine Ltd. (Subsidiary Company) to effect the transfer of said Net Assets at BDT 20,81,69,670.00 as at June 30, 2022 of Natural Medicine Division of The IBN SINA Pharmaceutical Industry Ltd. to its 99.99 % owned Subsidiary Company- The IBN SINA Natural Medicine Ltd. in exchange of consideration other than cash as against acquiring of Shares held by the holding Company, The IBN SINA Pharmaceutical Industry Ltd. (end)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
(IBNSINA-এর ধারাবাহিক সংবাদ): এবং IBN SINA ন্যাচারাল মেডিসিন লিমিটেড (সাবসিডিয়ারি কোম্পানি) 20,81,69,670.00 টাকায় উল্লিখিত নেট সম্পদ হস্তান্তর কার্যকর করবে 30 জুন, 2022 পর্যন্ত ফার্মা ইনসিনাডু-এর প্রাকৃতিক ওষুধ বিভাগের লিমিটেড এর 99.99% মালিকানাধীন সাবসিডিয়ারি কোম্পানি- দ্য আইবিএন সিনা ন্যাচারাল মেডিসিন লিমিটেড।
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6316cc51b2c25841948cef36
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from IBNSINA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.